Incyte (INCY) Tops Q3 EPS by 3c
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $120.52 -0.21%
Financial Fact:
Research and development: 143.18M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 143.18M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q3 EPS of $0.60, $0.03 better than the analyst estimate of $0.57. Revenue for the quarter came in at $823.3 million versus the consensus estimate of $845.6 million.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
